BioPharmX Invited to Present at 27th Annual Oppenh
Post# of 223
(Total Views: 4153)
Posted On: 03/21/2017 9:49:11 AM
BioPharmX Invited to Present at 27th Annual Oppenheimer Healthcare Conference
MENLO PARK, Calif., March 21, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, has been invited to present at Oppenheimer's 27th Annual Healthcare Conference in New York.
BioPharmX co-founder and President Anja Krammer will provide an overview of the company at the conference tomorrow at 1:00 p.m. EDT in the Consulate conference room of the Westin New York Grand Central. BioPharmX is one of about 100 companies selected to meet with individual investors and small groups.
The live webcast will be available at https://www.veracast.com/webcasts/opco/health...200176.cfm
The annual Oppenheimer Healthcare Conference, hosted by Oppenheimer & Co. March 21 and 22, is one of the most important investor conferences in the healthcare sector, providing the first glimpse into the issues and companies that will be prevalent in 2017.
MENLO PARK, Calif., March 21, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, has been invited to present at Oppenheimer's 27th Annual Healthcare Conference in New York.
BioPharmX co-founder and President Anja Krammer will provide an overview of the company at the conference tomorrow at 1:00 p.m. EDT in the Consulate conference room of the Westin New York Grand Central. BioPharmX is one of about 100 companies selected to meet with individual investors and small groups.
The live webcast will be available at https://www.veracast.com/webcasts/opco/health...200176.cfm
The annual Oppenheimer Healthcare Conference, hosted by Oppenheimer & Co. March 21 and 22, is one of the most important investor conferences in the healthcare sector, providing the first glimpse into the issues and companies that will be prevalent in 2017.
(0)
(0)BioPharmX Corporation (BPMX) Stock Research Links
Scroll down for more posts ▼